Better Choice Company Reports Record Second Quarter 2022 Gross Sales and Provides Corporate Update August 11, 2022
Lexaria Announces Positive Feedback from Pre-IND Meeting with FDA on DehydraTECH-CBD for Hypertension August 10, 2022
Lexaria Bioscience Corp. (NASDAQ: LEXX) Developing Powerful Tech to Treat Hypertension August 9, 2022